Alan Arnstein

Alan Arnstein is the Chief Business Development Officer at RAD Intel since May 2025, where responsibilities include leading growth and partnerships to enhance the AI Buyout (AIBO) strategy. Prior to this role, Alan served as President of Arnstein Consulting Inc. from 2023 to May 2025, focusing on strategic consulting for pharmacy and veterinary companies. From 2017 to 2023, Alan was the Vice President of Business Development at AmeriVet Veterinary Partners, driving the acquisition of veterinary hospitals across the U.S. Earlier in a lengthy career at Katz Group Canada, Alan held the position of Vice President of Business Development, successfully establishing over 100 Medicine Shoppe franchise pharmacies and integrating independent pharmacies into the Rexall network. Alan holds a Bachelor of Commerce degree from The University of British Columbia.